- Home
- BH vs CERT Comparison
BH vs CERT Comparison
Compare BH & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BH | CERT |
|---|---|---|
| Founded | 1934 | 2008 |
| Country | United States | United States |
| Employees | 2359 | N/A |
| Industry | Restaurants | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 971.1M | 860.9M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | BH | CERT |
|---|---|---|
| Price | $303.21 | $6.36 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $11.67 |
| AVG Volume (30 Days) | 58.0K | ★ 2.4M |
| Earning Date | 05-04-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $418,838,000.00 |
| Revenue This Year | N/A | $4.18 |
| Revenue Next Year | N/A | $5.39 |
| P/E Ratio | $597.67 | ★ N/A |
| Revenue Growth | N/A | ★ 8.75 |
| 52 Week Low | $230.12 | $5.19 |
| 52 Week High | $483.60 | $13.88 |
Technical Indicators
Market Signals| Indicator | BH | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 47.87 | 55.41 |
| Support Level | $299.54 | $5.93 |
| Resistance Level | $321.70 | $6.48 |
| Average True Range (ATR) | 13.06 | 0.28 |
| MACD | 0.75 | 0.04 |
| Stochastic Oscillator | 74.42 | 76.87 |
Price Performance
Historical ComparisonAbout BH Biglari Holdings Inc. Class B
Biglari Holdings Inc is a holding company that owns subsidiaries in a range of businesses. The company's reportable segments include Restaurant Operations, Insurance Operations, and Oil and Gas Operations. Its restaurant operations include Steak n Shake and Western Sizzlin. Its insurance operations include First Guard, Southern Pioneer, and Biglari Reinsurance. Oil and gas operations include Southern Oil and Abraxas Petroleum. The company also reports segment information for Maxim. The majority of revenue is derived from the Restaurant Operations Segment.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.